You're reading the free version. Trader adds the live tape and alerts.
Start tracking
LYEL Other Disclosure
Innovative Cellular Therapeutics Holdings Ltd · SEC Form 4 · Filed Jul 27, 2026
Other
Calculated transaction value
$0
Innovative Cellular Therapeutics Holdings Ltd 10% owner
LYEL
Lyell Immunopharma
LYEL
Transaction date
Jul 27, 2026
Public filing date
Jul 27, 2026
Filing lag
Filed same day
LYEL daily price context
Close on/before transaction
$12.96
Jul 27, 2026
First close after public filing
$12.99
Jul 28, 2026
30-day return after filing
+13.93%
Through Aug 26, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 44,000 shares @ $0
- SEC ownership
- Direct
- Transaction code
- J
- Form
- 4
- Filing identifier
- 0001140361-26-029817
Filing cohort
Transactions in this filing
Showing 1 of 1
Trades
1
Issuers
1
Estimated value
$0
Buys / sales
0 / 0
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Lyell Immunopharma, Inc. LYEL Current | Other | Jul 27, 2026 | $0 |